Manager or Director in projects supported by national organizations such as TUBITAK, DPT

  • Overcoming Bortezomib Resistance by Targeting the PI3K Signaling Pathway in the Treatment of Multiple Myeloma
    (2022-2023) İzmir University of Economics - SRP (BAP)
  • 1. Restoring the Therapy Efficiency for Imatinib Resistance in Ph+ Acute Lymphoblastic Leukemia by Drug Repurposing
    (2021-2022) TÜBİTAK